Thromb Haemost 2014; 112(04): 841
DOI: 10.1160/TH14-04-0325
Author Correspondence
Schattauer GmbH

Comment on: Editorial by Husted et al. “Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel”

Jack Ansell
1   Hofstra North Shore/LIJ School of Medicine, Hempstead, New York, USA
,
Mark Crowther
2   St. Joseph’s Healthcare, Hamilton, Ontario, Canada
3   McMaster University , Hamilton, Ontario, Canada
,
Allison Burnett
4   University of New Mexico College of Pharmacy, Albuquerque, New Mexico, USA
5   University of New Mexico Hospital, Albuquerque, New Mexico, USA
,
David Garcia
6   University of Washington Medical Center, Seattle, Washington, USA
,
Scott Kaatz
7   Michigan State University – College of Human Medicine, Grand Rapids, Michigan, USA
,
Renato D. Lopes
8   Duke University School of Medicine, Durham, North Carolina, USA
,
Edith Nutescu
9   University of Illinois Hospital and Health Sciences System, University of Illinois at Chicago; Chicago, Illinois, USA
,
Lynn Oertel
10   Massachusetts General Hospital, Boston, Massachusetts, USA
,
Terri Schnurr
2   St. Joseph’s Healthcare, Hamilton, Ontario, Canada
,
Michael Streiff
11   Johns Hopkins Medical Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
,
Diane Wirth
12   Grady Memorial, Delaware, Ohio, USA
,
Daniel Witt
13   University of Utah College of Pharmacy, Salt Lake City, Utah, USA
,
Ann Wittkowsky
14   UW Medicine Department of Pharmacy, University of Washington, Seattle, Washington, USA
,
for the Anticoagulation Forum › Author Affiliations
Further Information

Publication History

Received: 13 April 2014

Accepted after major revision: 07 May 2014

Publication Date:
04 December 2017 (online)

(Thromb Haemost 2014; 111: 781–782)

 
  • References

  • 1 Husted S, de Caterina R, Andreotti F. et al. Nonvitamin K antagonists oral anticoagulants (NOACs): No longer new or novel. Thromb Haemost 2014; 111: 781-782.
  • 2 ISMP Medication Safety Alert, December 12, 2013; Volume 18, issue 25.